A diagnostic challenge-First case of chronic lymphatic leukemia-associated necrotizing sweet syndrome.
Marie Anne-Catherine NeumannPascal NieperFlorian SimonAlexander Shimabukuro-VornhagenMichael HallekJorge Garcia BorregaPublished in: European journal of haematology (2023)
Sweet syndrome, also known as acute febrile neutrophilic dermatosis, is a rare disorder typically characterized by the clinical triad including a sudden onset of fever, painful skin lesions, and neutrophilia. The histopathological findings are a dense neutrophilic infiltrate and oedema of the dermis and epidermis without evidence of a vasculitis. Besides treatment of the underlying cause, sweet syndrome is typically treated with high-dose corticosteroids leading to a relapse-free response in 70% of patients. However, if left unrecognized or untreated, the condition may lead to serious complications. Here, we report on the case of a 38-year-old patient in whom, under the assumption of the presence of necrotizing fasciitis, exarticulation of the right arm was performed. In the absence of pathogen detection and insufficient response to anti-infective therapies, the diagnosis of a sweet syndrome was assumed and, later, confirmed by an excellent response to high-dose administration of systematic glucocorticoids. The case emphasizes the need to be aware of this rare syndrome, which can be easily misdiagnosed due to its close resemblance to infection and stresses the need of further research to define distinct diagnostic tools.
Keyphrases
- high dose
- case report
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- lymph node
- ejection fraction
- acute myeloid leukemia
- risk factors
- peritoneal dialysis
- intensive care unit
- liver failure
- stem cell transplantation
- prognostic factors
- patient reported outcomes
- aortic dissection
- label free
- smoking cessation